SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-20-001238
Filing Date
2020-09-08
Accepted
2020-09-08 16:46:47
Documents
13
Period of Report
2020-09-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52282047.htm   iXBRL 8-K 29860
2 EXHIBIT 99.1 a52282047ex99_1.htm EX-99.1 6033
  Complete submission text file 0001157523-20-001238.txt   178763

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA usna-20200904.xsd EX-101.SCH 4186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20200904_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20200904_pre.xml EX-101.PRE 16824
6 EXTRACTED XBRL INSTANCE DOCUMENT a52282047_htm.xml XML 4086
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 201164603
SIC: 2833 Medicinal Chemicals & Botanical Products